Nobivac Feline 1-HCP+FeLV (Box of 25 doses)

No reviews

$210.95

5575

Usually ships within 1 Business Day

FREE SHIPPING

Add to Wishlist

Product Description

Vaccines MUST be shipped via UPS Next Day Air or UPS 2nd Day Air with a cooler & ice packs. Failure to do so may result in a delay in the shipment of your order. Any vaccine order processed Thursday without next day air shipping or any vaccine orders placed Friday-Sunday will be shipped the following Monday. Contact our Customer Support team for more information.

Please allow one (1) business day for processing.

Nobivac Feline 1-HCP+FeLV

(Formerly Eclipse 3 + FeLV)

The only combination vaccine that provides a 2-year duration of immunity for feline leukemia virus (FeLV) in addition to 1-year protection against feline rhinotracheitis, calicivirus, and panleukopenia.

  • A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), and feline calicivirus (FCV), in addition to providing extensive 2-year coverage for FeLV
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats1
    • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia2-4
  • The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination5
  • Superior Efficacy demonstrated vs. multiple FeLV vaccines6,7
    • The ONLY USDA-licensed 2-Year Duration of immunity (DOI) FeLV vaccine1,5 (Ideal for adherence to AAFP guidelines8)
    • The ONLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real-life conditions
  • Proven safety profile- 99% reaction-free in ongoing surveillance involving millions of doses1
  • The optimal choice for both indoor and outdoor cats of all ages and for all cats under 1 year of age
  • Approved for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses
  • Approved as an aid in the prevention of lymphoid tumors caused by, and diseases associated with feline leukemia virus (FeLV) infection
  • Vaccination with this product prevents persistent viremia in cats exposed to virulent FeLV
  • Recommended for use in healthy cats 9 weeks of age or older

Administration and Dosage
For cats 9 weeks of age or older:

  • Subcutaneous or intramuscular injection
  • Initial 1-mL dose administered at 9 weeks of age or older
  • Second 1-mL dose administered 3 to 4 weeks later
  • Revaccination every 2 years with 1 dose of Nobivac® Feline 1-HCP+FeLV is recommended
  • Revaccination in the intervening years with Nobivac® Feline 1-HCP is recommended

Product Review

Related Products